Literature DB >> 13116122

Estimation of the antileukemic potency of the antimetabolite aminopterin, administered alone and in combination with citrovorum factor or folic acid.

A GOLDIN, N MANTEL, S W GREENHOUSE, J M VENDITTI, S R HUMPHREYS.   

Abstract

Entities:  

Keywords:  AMINOPTERIN/effects; FOLIC ACID/effects; LEUKEMIA, LYMPHATIC/experimental

Mesh：

Substances：

Year:  1953        PMID： 13116122

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  5 in total

1.  The impact of 5-formyltetrahydrofolate on the anti-tumor activity of pralatrexate, as compared to methotrexate, in HeLa cells in vitro.

Authors:  Michele Visentin; Ersin Selcuk Unal; I David Goldman
Journal:  Cancer Chemother Pharmacol       Date:  2014-03-29       Impact factor: 3.333

2.  High-dose methotrexate with citrovorum factor rescue in non-small-cell lung cancer.

Authors:  F A Greco; M F Fer; R L Richardson; K R Hande; C J Van Boxtel; R K Oldham
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

3.  Serum, tear and salivary concentrations of methotrexate in man.

Authors:  W H Steele; J F Stuart; B Whiting; J R Lawrence; K C Calman; J G McVie; G M Baird
Journal:  Br J Clin Pharmacol       Date:  1979-02       Impact factor: 4.335

4.  Reduction in the toxicity of aminopterin--monoclonal-antibody conjugates by leucovorin.

Authors:  A J Rowland; G A Pietersz
Journal:  Cancer Immunol Immunother       Date:  1994-08       Impact factor: 6.968

5.  Patient-derived oral mucosa organoids as an in vitro model for methotrexate induced toxicity in pediatric acute lymphoblastic leukemia.

Authors:  E Driehuis; N Oosterom; S G Heil; I B Muller; M Lin; S Kolders; G Jansen; R de Jonge; R Pieters; H Clevers; M M van den Heuvel-Eibrink
Journal:  PLoS One       Date:  2020-05-18       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.